New
DPDP Act compliance check for companies
, core duties apply from 13 May 2027
Know more
Justis AI
Product
Solutions
Use cases
Resources
Pricing
Sign In
Book Now
US law
Federal (United States)
Regulations
Title 21 CFR — Food and Drugs
Chapter I — FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES
Part 314 — APPLICATIONS FOR FDA APPROVAL TO MARKET A NEW DRUG
Subpart I — Approval of New Drugs When Human Efficacy Studies Are Not Ethical or Feasible
Federal (United States) · Regulations
Subpart I — Approval of New Drugs When Human Efficacy Studies Are Not Ethical or Feasible
6 sections
6 sections
21 C.F.R. § 314.600
Scope.
21 C.F.R. § 314.610
Approval based on evidence of effectiveness from studies in animals.
21 C.F.R. § 314.620
Withdrawal procedures.
21 C.F.R. § 314.630
Postmarketing safety reporting.
21 C.F.R. § 314.640
Promotional materials.
21 C.F.R. § 314.650
Termination of requirements.
Subpart I — Approval of New Drugs When Human Efficacy Studies Are Not Ethical or Feasible | Federal (United States) Regulations | Justis AI